Project Grant R21AG094047
Award Date
5/15/25
Completion Date
4/30/27
Dollars Obligated
$443K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Cleveland, OH 44106, USA
Similar Awards
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports a research effort to identify novel small molecules that can stabilize functional TDP43 multimers and restore TDP43 activity. The $404,058 grant, with a performance period from May 1, 2025 to April 30, 2027, will fund the development of a high-throughput screening pipeline to screen compound libraries and discover molecules that can prevent the loss of TDP43's native function. The research...
The National Institute on Aging awarded Case Western Reserve University $1,785,220 under the Aging Research program (CFDA 93.866) from May 2022 to April 2025. The university will research the role of deubiquitinase USP19 in the pathogenesis of TDP-43, a protein implicated in neurodegenerative diseases like frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Using mouse models, human post-mortem tissues, and molecular and cell biology techniques, the university aims to validate...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $757,027 to the University of Washington to support research on the synergistic relationship between tau and TDP-43 proteins in Alzheimer's disease (AD). The award period is from January 1, 2025 to December 31, 2029. The key objectives are to: 1) further investigate the mechanistic pathways by which tau and TDP-43 may interact to exacerbate proteotoxicity in AD, focusing on the lysosomal...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to The Regents of the University of California, San Francisco (UCSF) provides $1,275,512 in funding over 2 years from June 1, 2025 to May 31, 2027. The objective is to determine how different forms of the protein progranulin (PGRN) impact the accumulation of the TDP-43 protein, which is associated with neurodegenerative diseases like Alzheimer's, frontotemporal dementia, and limbic-predominant...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports scientific research into the neuropathological features and molecular signatures of Frontotemporal Lobar Degeneration with Transactive Response DNA-Binding Protein Type C (FTLD-TDP Type C). The $786,632 award to Northwestern University, with a performance period from December 1, 2024 to November 30, 2029, will expand on prior discoveries regarding the impact of FTLD-TDP Type C on the...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders federal grant program (CFDA 93.853), is funding the development and optimization of a new animal model for amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The award aims to demonstrate a progressive ALS/FTD-like phenotype using aged mouse cohorts and validate the animal findings through...
This National Institute on Aging (NIA) Project Grant award under the Aging Research program (CFDA 93.866) provides $104,164.00 to Emory University to explore the role of the TMEM106B protein in neurodegeneration. The key objectives are to: 1) determine the interaction between TMEM106B and the C9ORF72 repeat expansion, which is linked to frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS); and 2) investigate the toxicity of TMEM106B protein aggregates and their impact on...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $461,900.00 to Pennsylvania State University to study the role of the TDP-43 protein in muscle degeneration associated with amyotrophic lateral sclerosis (ALS) and other neuromuscular disorders. The key objectives are to: 1) Identify TDP-43 translation targets in Drosophila muscle models using overexpression and loss-of-function approaches, and 2) Validate candidate TDP-43 target genes in fly...
This $2,219,913 Project Grant award from the National Institute on Aging's Aging Research Federal Grant Program (CFDA 93.866) aims to investigate the link between environmental risk factors and TDP-43 proteinopathies, which are associated with neurodegenerative disorders like frontotemporal dementia (FTD), amyotrophic lateral sclerosis (ALS), and Alzheimer's disease. The research team at the University of North Carolina at Chapel Hill will perform high-content screening to identify environmental...
This Project Grant award from the National Institute on Aging's Aging Research Federal Grant Program (CFDA 93.866) supports research into the mechanisms and toxicity of chimeric dipeptide repeat (CDPR) proteins in C9ALS/FTD, a genetic form of amyotrophic lateral sclerosis and frontotemporal dementia. The $1,938,189 award to Emory University aims to: 1) identify the complexity, extent, and mechanism of CDPR pathology in C9ALS/FTD; 2) determine the molecular consequences and neuronal toxicity of...